$CHRW

C.H. Robinson to buy RXO for $5.8bn: deal terms and timeline %sep% %sitename%

C.H. Robinson (CHRW) will acquire RXO (RXO) for $5.8bn, offering $17.25 cash plus 0.0856 CHRW shares per RXO share, a 29% premium. RXO shareholders will own 11% of the combined entity. CHRW expects $300m in cost synergies and AI-driven efficiencies. RXO shares rose 24%, while CHRW fell 9% on deal announcement.

Original reporting
Published Oct 6, 2026, 10:53 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
C.H. Robinson to buy RXO for $5.8bn: deal terms and timeline %sep% %sitename% — source image
Decision brief

The 30-second read

$CHRWBearishHigh
01

Why it matters

The deal creates a larger, AI‑enabled logistics platform but introduces dilution and debt concerns for CHRW while delivering a premium cash payout for RXO shareholders.

02

Market read

A $5.8bn merger reshapes the North American freight brokerage market, prompting immediate price moves and sector‑wide strategic reassessment.

03

What to watch

Potential regulatory scrutiny and the impact of higher leverage on CHRW's credit profile.

Relevance 9/10Novelty 9/10Timing: today

Background

The article details the terms, financing, and immediate market reaction to C.H. Robinson's announced acquisition of RXO.

Company-level read

Ticker impact

$CHRWBearishHigh confidence
Context

C.H. Robinson announced a $5.8bn acquisition of RXO, causing its stock to fall about 9% on dilution and new debt concerns.

Expected impact

likely further downside as market prices in higher debt and dilution.

Evidence & confidence

The deal finances 57% cash with new debt and pauses share buybacks, signaling lower near‑term earnings per share.

$RXOBullishHigh confidence
Context

RXO shareholders receive cash and CHRW stock in the $5.8bn deal, driving RXO shares up roughly 24% at the open.

Expected impact

likely continued upside as the premium and cash consideration are priced in.

Evidence & confidence

A 29% premium to recent price and cash payout provide immediate value to shareholders.

Market effects

Consolidation in freight brokerage may spur further M&A activity in logistics.

U.S. logistics sector sees heightened volatility as investors reassess valuation multiples.

Large‑scale deal highlights AI‑driven efficiency trends affecting global supply‑chain players.

Counterpoint

The acquisition could overpay for RXO, and integration risk may erode expected synergies.

Key entities

  • C.H. Robinson

    U.S. logistics provider acquiring RXO.

  • RXO

    Freight brokerage spun off from XPO, target of the acquisition.

Related articles

$CHRWHighAI 9/10

Q&A: Michael Castagnetto, President, North American Surface Transportation, C.H. Robinson

C.H. Robinson (CHRW) agreed to acquire RXO in a $5.8B cash-and-stock deal, expected to close by mid-2027. The acquisition aims to expand CHRW's scale, technology, and service offerings, particularly in last-mile and expedite services. RXO's strengths in healthcare and automotive sectors, along with its technology, are key drivers. Integration will focus on combining data, technology, and lean AI strategies.

$RXOHighAI 9/10

Why RXO (RXO) Is Getting So Much Attention Now

C.H. Robinson Worldwide agreed to acquire RXO (RXO) in a $5.8b cash and stock deal. RXO's stock surged 38.61% in 7 days and 37.27% in 30 days, with a 120.87% year-to-date return. The stock closed at $28.36, above a fair value estimate of $26.23, but faces risks from soft freight conditions and legal liabilities.

$CHRWHighAI 9/10

Analysts see promise, risks in C.H. Robinson-RXO deal

C.H. Robinson (CHRW) plans to acquire RXO in a $5.8B deal, creating a company with over $25B enterprise value. Analysts see strategic benefits, including expanded brokerage scale and cost synergies, but warn of integration risks and legal uncertainties. CHRW's stock initially dropped post-announcement, with analysts citing long-term potential.